DOX Quote, Financials, Valuation and Earnings

ASGN Incorporated has a net margin of 13.71% compared to Amdocs Ltd.'s net margin of 2.57%. Amdocs Ltd.'s return on equity of 16.29% beat ASGN Incorporated's return on equity of 6.28%.

Amdocs Ltd. has a consensus price target of $95.50, signalling upside risk potential of 35.51%. On the other hand ASGN Incorporated has an analysts' consensus of $54.50 which suggests that it could grow by 31.55%. Given that Amdocs Ltd. has higher upside potential than ASGN Incorporated, analysts believe Amdocs Ltd. is more attractive than ASGN Incorporated.

Amdocs Ltd. has a beta of 0.404, which suggesting that the stock is 59.602% less volatile than S&P 500. In comparison ASGN Incorporated has a beta of 0.865, suggesting its less volatile than the S&P 500 by 13.481%.

Amdocs Ltd. has a quarterly dividend of $0.53 per share corresponding to a yield of 3.05%. ASGN Incorporated offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amdocs Ltd. pays 40.77% of its earnings as a dividend. ASGN Incorporated pays out -- of its earnings as a dividend. Amdocs Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Amdocs Ltd. quarterly revenues are $1.2B, which are larger than ASGN Incorporated quarterly revenues of $980.1M. Amdocs Ltd.'s net income of $158.5M is higher than ASGN Incorporated's net income of $25.2M. Notably, Amdocs Ltd.'s price-to-earnings ratio is 13.45x while ASGN Incorporated's PE ratio is 16.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs Ltd. is 1.66x versus 0.46x for ASGN Incorporated. Usually stocks with elevated PS ratios are considered overvalued.

CDW Corp. has a net margin of 13.71% compared to Amdocs Ltd.'s net margin of 5.07%. Amdocs Ltd.'s return on equity of 16.29% beat CDW Corp.'s return on equity of 43.4%.

Amdocs Ltd. has a consensus price target of $95.50, signalling upside risk potential of 35.51%. On the other hand CDW Corp. has an analysts' consensus of $170.40 which suggests that it could grow by 34.32%. Given that Amdocs Ltd. has higher upside potential than CDW Corp., analysts believe Amdocs Ltd. is more attractive than CDW Corp..

Amdocs Ltd. has a beta of 0.404, which suggesting that the stock is 59.602% less volatile than S&P 500. In comparison CDW Corp. has a beta of 1.079, suggesting its more volatile than the S&P 500 by 7.922%.

Amdocs Ltd. has a quarterly dividend of $0.53 per share corresponding to a yield of 3.05%. CDW Corp. offers a yield of 1.98% to investors and pays a quarterly dividend of $0.63 per share. Amdocs Ltd. pays 40.77% of its earnings as a dividend. CDW Corp. pays out 31% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Amdocs Ltd. quarterly revenues are $1.2B, which are smaller than CDW Corp. quarterly revenues of $5.5B. Amdocs Ltd.'s net income of $158.5M is lower than CDW Corp.'s net income of $279.5M. Notably, Amdocs Ltd.'s price-to-earnings ratio is 13.45x while CDW Corp.'s PE ratio is 15.70x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs Ltd. is 1.66x versus 0.75x for CDW Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Concentrix Corp. has a net margin of 13.71% compared to Amdocs Ltd.'s net margin of -57.73%. Amdocs Ltd.'s return on equity of 16.29% beat Concentrix Corp.'s return on equity of -33%.

Amdocs Ltd. has a consensus price target of $95.50, signalling upside risk potential of 35.51%. On the other hand Concentrix Corp. has an analysts' consensus of $62.20 which suggests that it could grow by 104.71%. Given that Concentrix Corp. has higher upside potential than Amdocs Ltd., analysts believe Concentrix Corp. is more attractive than Amdocs Ltd..

Amdocs Ltd. has a beta of 0.404, which suggesting that the stock is 59.602% less volatile than S&P 500. In comparison Concentrix Corp. has a beta of 0.501, suggesting its less volatile than the S&P 500 by 49.868%.

Amdocs Ltd. has a quarterly dividend of $0.53 per share corresponding to a yield of 3.05%. Concentrix Corp. offers a yield of 4.56% to investors and pays a quarterly dividend of $0.36 per share. Amdocs Ltd. pays 40.77% of its earnings as a dividend. Concentrix Corp. pays out 33.39% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Amdocs Ltd. quarterly revenues are $1.2B, which are smaller than Concentrix Corp. quarterly revenues of $2.6B. Amdocs Ltd.'s net income of $158.5M is higher than Concentrix Corp.'s net income of -$1.5B. Notably, Amdocs Ltd.'s price-to-earnings ratio is 13.45x while Concentrix Corp.'s PE ratio is 8.55x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs Ltd. is 1.66x versus 0.20x for Concentrix Corp.. Usually stocks with elevated PS ratios are considered overvalued.

CSP, Inc. has a net margin of 13.71% compared to Amdocs Ltd.'s net margin of 0.72%. Amdocs Ltd.'s return on equity of 16.29% beat CSP, Inc.'s return on equity of -1.03%.

Amdocs Ltd. has a consensus price target of $95.50, signalling upside risk potential of 35.51%. On the other hand CSP, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Amdocs Ltd. has higher upside potential than CSP, Inc., analysts believe Amdocs Ltd. is more attractive than CSP, Inc..

Amdocs Ltd. has a beta of 0.404, which suggesting that the stock is 59.602% less volatile than S&P 500. In comparison CSP, Inc. has a beta of 0.732, suggesting its less volatile than the S&P 500 by 26.78%.

Amdocs Ltd. has a quarterly dividend of $0.53 per share corresponding to a yield of 3.05%. CSP, Inc. offers a yield of 1.22% to investors and pays a quarterly dividend of $0.03 per share. Amdocs Ltd. pays 40.77% of its earnings as a dividend. CSP, Inc. pays out 312.27% of its earnings as a dividend. Amdocs Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CSP, Inc.'s is not.

Amdocs Ltd. quarterly revenues are $1.2B, which are larger than CSP, Inc. quarterly revenues of $12M. Amdocs Ltd.'s net income of $158.5M is higher than CSP, Inc.'s net income of $86K. Notably, Amdocs Ltd.'s price-to-earnings ratio is 13.45x while CSP, Inc.'s PE ratio is 1,433.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs Ltd. is 1.66x versus 1.69x for CSP, Inc.. Usually stocks with elevated PS ratios are considered overvalued.